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Purpose: To verify the usefulness of the Thyroid Imaging Reporting and Data System (TI-RADS) 
for thyroid nodule diagnosis by less experienced physicians.
Methods: From March 2012 to May 2012, ultrasonography-guided fine needle aspiration 
was performed in 204 thyroid nodules in 195 consecutive patients by four less experienced 
radiologists (<1 year in thyroid imaging). The number of suspicious ultrasonography features and 
the total risk score of each thyroid nodule were calculated according to the previous two models 
suggested by Kwak et al. The Delong method was used to compare the areas under the curve 
(AUCs) of the two models. Associations between the two models and the risk of malignancy 
were analyzed using penalized B-splines and the Cochran-Armitage trend test. 
Results: Among 204 thyroid nodules, 65 were malignant and 139 were benign. The probability 
of malignancy tended to increase as the number of suspicious ultrasonography features, and the 
sum of risk scores increased. There was no significant difference in the AUCs of the two models 
(P=0.673). The Cochran-Armitage trend test demonstrated an increased risk of malignancy as 
the number of suspicious ultrasonography features and the total risk score increased (P=0.001). 
Conclusion: Both the number of suspicious ultrasonography features and the total risk score 
are applicable and show comparable results in the risk stratification of thyroid nodules by less 
experienced radiologists in thyroid imaging. 
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Introduction
The number of diagnosed nonpalpable thyroid nodules is increasing as a consequence of the 
widespread use of ultrasonography (US) in health surveilance and an increase in the use of US-
guided fine needle aspiration (US-FNA) [1]. Thyroid nodules are found in up to 67% of adults by 
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US [2]. However, fewer than 5.0%-6.5% of incidently discovered 
thyroid nodules are malignant [3]. Thus, it is important that criteria 
be established for selecting thyroid nodules for FNA according to 
malignancy risk.  
US is an important diagnostic tool in predicting thyroid maligancy 
and selecting thyroid nodules that should be assessed by FNA [4-
6]. Known suspicious US features include marked hypoechogenicity, 
microlobulated or irregular margins, microcalcifications, and a taller-
than-wide shape; a combination of these features is known to 
provide better diagnostic accuracy than a single feature alone [4,7,8]. 
Many organizations have recommended guidelines for the selection 
of thyroid nodules for biopsy using size criteria or suspicious US 
features [9-12]. However, various terms such as probably benign, 
indeterminate, low suspicion, and suspicious and different criteria 
hinder effective communication between reporting radiologists and 
clinicians. In breast imaging, the Breast Imaging Reporting and 
Data System (BI-RADS) is widely used to assess the probability of 
malignancy and need for biopsy [13]. Based on this system, breast 
nodules can be established with a certain malignancy rate for 
each category. Similar to BI-RADS, the Thyroid Imaging Reporting 
and Data System (TI-RADS) was developed for risk stratification of 
thyroid nodules using US features [14-16]. 
Although several studies have suggested that TI-RADS helps 
avoid confusion among physicians and patients and reduces 
unnecessary benign cytologic results, applying this approach is 
difficult in daily practice because of its complexity. In a study looking 
for novel approaches to overcome the complexity of TI-RADS, Kwak 
et al. [17] recently reported that as the number of suspicious US 
features increased, the fitted probability and risk of malignancy also 
increased. They also demonstrated that the following US features 
showed a significant association with malignancy: solid component, 
hypoechogenicity, marked hypoechogenicity, microlobulated or 
irregular margins, microcalcifications, and taller-than-wide shape 
[17]. However, this study was limited, in that each suspicious 
US feature was regarded with the same weight of malignancy 
probability. Thereafter, a diagnostic prediction model derived 
from the total risk score was proposed that reflected the different 
probablities of malignancy from each suspicious US feature, and the 
resulting model showed that US risk scores could predict thyroid 
malignancy well [18]. However, radiologists involved in these 
previous studies had more than 5 years of experience in thyroid 
imaging. Therefore, the purpose of this study was to verify the 
usefulness of TI-RADS among less experienced physicians with less 
than 1 year experience in thyroid imaging. 
Materials and Methods
 
Study Population
This retrospective study was approved by the Institutional Review 
Board and required neither patient approval nor informed consent 
for review of patients’ images and medical records. However, written 
informed consent was obtained from all patients for US-FNA prior 
to each procedure according to our hospital's regular policy. From 
March 2012 to May 2012, 259 consecutive thyroid nodules of 
248 patients were imaged with gray-scale US and US-FNA was 
performed by 4 less experienced radiologists. Of these, 55 thyroid 
nodules including indeterminate (n=15) or nondiagnostic results 
(n=40) at cytologic evaluation were excluded because they did not 
undergo surgery or repeat US-FNA. Inclusion criteria were as follows: 
(1) thyroid nodules in which thyroid surgery was performed (n=63); 
(2) benign or malignant results at cytologic evaluation (n=139); and 
(3) benign or malignant results at US-FNA or thyroid surgery after 
nondiagnostic cytologic results (n=2). Finally, 204 thyroid nodules 
in 195 patients (26 men and 169 women; mean age, 51 years; 
age range, 16 to 88 years) were enrolled in this study. Among 204 
thyroid nodules, 65 nodules (32%) were malignant and 139 (68%) 
were benign. Pathologic results confirmed after operation are shown 
in Table 1.
Real-time Gray-scale US
Real-time gray-scale US was independently performed by one of four 
board-certified less experienced radiologists (<1 year experience 
in thyroid imaging), who were assigned arbitrarily according to 
the hospital’s daily schedule, using a 6- to 14-MHz linear array 
transducer (EUB-7500, Hitachi Medical, Tokyo, Japan) or a 5- to 
12-MHz linear array transducer (iU 22, Philips Medical Systems, 
Bothell, WA, USA). Before this study, each radiologist had experience 
performing thyroid US for 8, 9, 7, and 7 months, respectively, during 
resident practice in different hospitals. During this study period, 
all four radiologists had undergone fellowship training in thyroid 
Table 1. Pathology of 63 nodules confirmed after operation
Variable Nodule
Benign (n=3)
      Adenomatous hyperplasia 3
Malignant (n=60)
      Papillary carcinoma
            Conventional 52
            Follicular variant  6
      Follicular carcionoma
            Subtype not described 2TI-RADS by less experienced physicians
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imaging for 1 month in the same hospital. Of 204 thyroid nodules 
in this study, 15, 39, 55, and 95 thyroid nodules were imaged by 
physicians 1, 2, 3, and 4, respectively.
The US features of all of the thyroid nodules were prospectively 
recorded for clinical use according to the internal component, 
echogenicity, margins, calcifications, shape, and final assessment 
by the radiologists who had performed US. The internal component 
was classified as complete solid, cystic portion greater than 50%, or 
cystic portion less than or equal to 50%. Echogenicity was classified 
as hyperechogenicity, isoechogenicity, or hypoechogenicity (with 
respect to normal thyroid parenchyma), or marked hypoechogenicity 
(defined as lower echogenicity than the strap muscle). Margins were 
classified as well-defined, microlobulated, or irregular. Calcifications 
were classified as microcalcification (less than or equal to 1 mm in 
diameter; tiny, punctuate, hyperechoic foci, either with or without 
acoustic shadows), macrocalcification, or no calcification. Shape was 
defined as taller-than-wide (ratio of the anteroposterior diameter to 
the transverse diameter ≥1) or wider-than-tall. Suspicious features 
of thyroid nodules on US included marked hypoechogenicity, 
lack of well-defined margins, microcalcifications, and taller-than-
Fig. 1. Ultrasonography (US) images in a 40-year-old woman who underwent a routine check-up. 
A 18-mm thyroid mass in the left thyroid gland shows mixed isoechogenicity, a well-defined margin, and parallel orientation without 
suspicious features on US (A, transverse image; B, longitudinal image). Thyroid Imaging Reporting and Data System category 3 and a total 
risk score of 0 were assigned. This thyroid nodule was diagnosed as negative for malignancy on cytologic examination and showed no 
change at follow-up US.
A B
Fig. 2. Ultrasonography (US) images in a 58-year-old woman undergoing a routine examination. 
A 14-mm thyroid mass in the right thyroid gland shows two suspicious US features: complete solid and taller-than-wide shape on US (A, 
transverse image; B, longitudinal image). Thyroid Imaging Reporting and Data System category 4b and a total risk score of 1 were assigned. 
This thyroid nodule was diagnosed as malignant on cytological examination and proved to be papillary thyroid cancer on surgery.
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wide shape. All of the radiologists classified the thyroid nodules 
into two categories, as either positive for malignancy or negative 
for malignancy [4,7]. When thyroid nodules showed any of the 
suspicious features, they were classified as positive for malignancy. 
When thyroid nodules showed none of the suspicious features, they 
were classified as negative for malignancy. 
US-FNA was performed on thyroid nodules with suspicious US 
features or the largest of thyroid nodules in patients with multiple 
thyroid nodules that did not have suspicious US features [4,7]. US-
FNA was performed with a 23-gauge needle attached to a 2-mL 
disposable plastic syringe, and each lesion was aspirated at least 
twice with the freehand technique. Samples obtained were expelled 
on glass slides, smeared, and placed immediately in 95% alcohol 
for Papanicolaou staining. The remaining material in the syringe 
was rinsed in saline for cell block processing [19]. Cytopathologists 
were not on site during the aspiration procedure, and the cytology 
slides were interpreted by an experienced pathologist to confirm 
the cytologic diagnosis. Based on the Bethesda System for 
Reporting Thyroid cytology, FNA cytology results were classified 
as nondiagnostic, benign, atypia of undetermined significance/
follicular lesion of undetermined significance (AUS/FLUS), suspicious 
for follicular neoplasm or suspicious for a Hurthle cell neoplasm, 
suspicious for malignancy, and malignant [20].
The number of suspicious US features of each thyroid nodule was 
counted using our prospectively recorded US data. Based on the 
results of a previous study, a solid component, hypoechogenicity, 
marked hypoechogenicity, microlobulated or irregular margins, 
microcalcifications, and a taller-than-wide shape were counted as 
suspicious US features [17]. We applied TI-RADS category 3 (probably 
benign) to nodules with no suspicious US feature (Fig. 1), category 
4a (low suspicion for malignancy) to nodules with one suspicious 
US feature, category 4b (intermediate concern for malignancy) to 
nodules with two suspicous US features, category 4c (moderate 
concern but not classic for malignancy) to nodules with three or four 
suspicous US features (Fig. 2), and category 5 (highly suggestive 
of malignancy) to nodules with five suspicious US features (Fig. 3), 
respectively, according to the results of a previous study [17]. 
Another study proposed a new prediction model derived from 
the total risk score that took into consideration the different risk 
scores of each suspicious US feature [18]. They estimated the risk 
score for each suspicious US feature by calculating the odds ratios 
of thyroid malignancy. Based on this recent study by Kwak et al. [18], 
we applied a score of 2 to hypoechogenicity, a score of 6 to marked 
Table 2. Demographics of patients and thyroid nodules included 
in this study 
Variable Malignant (n= 65) Benign (n=139) P-value
Mean age (yr) 49.2±13.7 51.2±14.4 0.350
a)
Gender
Women (n=169) 58 (89.2) 118 (84.9) 0.514
b)
Men (n=26) 7 (10.8) 21 (15.1)
Nodule size (mm) 12.6±11.2 17.9±11.6 0.003
a)
 Values are presented as mean±SD or number (%).
a) P-value by using independent two-sample t-test. 
b) P-value by using chi-squared 
test.
Fig. 3. Ultrasonography (US) images in a 25-year-old woman who underwent a routine check-up. 
A 10-mm thyroid mass in the right thyroid gland is seen to be a complete solid with hypoechogenicity, an irregular margin, and a taller-than-
wide shape on US (A. transverse image; B. longitudinal image). Thyroid Imaging Reporting and Data System category 5 and a total risk score 
of 10 were assigned. This thyroid nodule was diagnosed as malignant on cytological examination and proved to be papillary thyroid cancer 
on surgery.
A BTI-RADS by less experienced physicians
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hypoechogenicity, a score of 1 to a taller-than-wide shape, a score 
of 5 to microlobulated or irregular margins, and a score of 2 to 
microcalcifications. Then, the total risk score of each thyroid nodule 
was calculated by summing the scores of each suspicious US feature, 
and the percentage chance of malignancy was obtained according 
to the total risk score. 
Statistical Analysis 
To determine the association between malignancy and patient 
age and nodule size, an independent two-sample t-test was used. 
Patient gender was compared between benign and malignant 
nodules using the chi-squared test. The rate of malignancy in thyroid 
nodules according to the TI-RADS category were also calculated. 
The ROC analysis was performed to assess the accuracy of two 
models predicting thyroid malignancy derived from the number 
of suspicious US features and total risk score. The Delong method 
was used to compare the AUCs of the two prediction models. The 
associations between the two models and the risk of malignancy 
were determined using penalized B-splines and the Cochran-
Armitage trend test. Analysis was performed with SAS ver. 9.2 (SAS 
Institute, Cary, NC, USA). Statistical significance was assumed when 
the P-value was less than 0.05. All reported P-values are 2-sided.
Results
Table 2 shows the patient demographics. The mean size of the 
Table 3. Percentage of malignancy according to the no. of suspicious US features
TI-RADS category
Percentage of malignancy according to the number of 
suspicious US features
a)
Physician 1 
(n=15)
Physician 2 
(n=39)
Physician 3 
(n=55)
Physician 4 
(n=95) All
3. Probably benign (no suspicious US features) 0 (0/0) 0 (0/7) 0 (0/10) 16.7 (1/6) 4 (1/23)
4. a. Low suspicion for malignancy (one suspicious US feature) 0 (0/6) 0 (0/9) 0 (0/7) 0 (0/21) 0 (0/43)
  b. Intermediate concern for malignancy (two suspicious US features) 0 (0/3) 0 (0/7) 8.3 (1/12) 26.7 (4/15) 13.5 (5/37)
  c. Moderate concern but not classic for malignancy 
      (three or four suspicious US features)
83.3 (5/6) 71.4 (10/14) 38.4 (5/13) 53.1 (26/49) 56.1 (46/82)
5. Highly suggestive of malignancy (five suspicious US features) 0 (0/0) 100 (2/2) 69.2 (9/13) 50 (2/4) 68.4 (13/19)
US, ultrasonography; TI-RAS, Thyroid Imaging Reporting and Data System.
a) Values are percentages of maligant cases with the given TI-RADS category. The number of cases used to calculate the percentages are in parentheses.
Fig. 4. Ultrasonography (US) images in a 47-year-old woman who underwent a routine check-up. 
A 36-mm thyroid mass in the right thyroid gland shows the features of predominantly solid, isoechogenicity, a well-defined margin, and a 
parallel orientation on US (A. transverse image; B. longitudinal image). Thyroid Imaging Reporting and Data System category 3 and a total 
risk score of 0 were assigned. This nodule was assessed as negative for malignancy on US. However, this thyroid nodule was diagnosed as 
suspicious for malignancy on cytologic examination and proved to be conventional papillary thyroid carcinoma on surgery.
A BSu Yeon Ko, et al.
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classified into TI-RADS categories 3, 4a, 4b, 4c, and 5, respectively 
(Table 3). Of the cases of 65 thyroid cancer, 1 (2%), 5 (7%), 46 (71%), 
and 13 (20%) nodules were subgrouped into TI-RADS categories 3, 
4b, 4c, and 5, respectively (Table 3). The percentage of malignancy 
according to the sum of risk scores for each thyroid nodule is shown 
in Table 4. The malignancy rate was 2.2% (1/46) in the thyroid 
nodules with the sum of risk scores presenting as zero (Fig. 4). The 
thyroid nodules was 16.2±11.6 mm (range, 2 to 65 mm). The 
malignant nodules were significantly smaller than the benign 
nodules (mean size, 12.6±11.2 mm vs. 17.9±11.6 mm, respectively; 
P=0.003). Gender did not differ significantly between the malignant 
and benign nodules (P=0.514), nor did age (P=0.350).  
Of the 204 thyroid nodules, 4% (1/23), 0% (0/43), 13.5% 
(5/37), 56.1% (46/82), and 68.4% (13/19) of the carcinomas were 
Table 4. Percentage of malignancy according to the sum of the risk scores
Sum of risk scores
b) Percentage of malignancy according to the sum of risk scores
a)
Physician 1 (n=15) Physician 2 (n=39) Physician 3 (n=55) Physician 4 (n=95) All
0 0 (0/6) 0 (0/14) 0 (0/14) 8.3 (1/12) 2.2 (1/46)
1 0 0 (0/1) 0 (0/6) 0 (0/1) 0 (0/8)
2 0 (0/2) 0 (0/7) 14.3 (1/7) 13.3 (4/30) 10.9 (5/46)
3 0 100 (2/2) 25.0 (1/4) 0 (0/2) 37.5 (3/8)
4 0 0 (0/2) 0 75.0 (3/4) 50.0 (3/6)
5 0 (0/1) 50 (1/2) 0 (0/1) 33.3 (1/3) 28.6 (2/7)
6 0 0 0 0 0
7 0 66.7 (2/3) 0 (0/2) 70.0 (7/10) 60 (9/15)
8 75.0 (3/4) 100 (3/3) 33.3 (1/3) 60.0 (12/20) 63.3 (19/30)
9 100 (1/1) 66.7 (2/3) 0 (0/2) 33.3 (3/9) 40 (6/15)
10 0 100 (2/2) 62.5 (5/8) 50.0 (2/4) 64.3 (9/14)
11 0 0 0 0 0
12 0 0 100 (3/3) 0 100 (3/3)
13 100 (1/1) 0 0 0 100 (1/1)
14 0 0 80.0 (4/5) 0 80.0 (4/5)
a) Values are percentages of maligant cases with the given total risk score obtained by summing the score of suspicious ultrasonography features. The number of cases used to 
calculate the percentages are in parentheses. 
b) Sum of all scores of individual items.
Fig. 5. Penalizd B-splines for the two models of Thyroid Imaging Reporting and Data System. 
The risk of malignancy tends to increase according to the number of suspicious ultrasonography features (A) and the total risk score of each 
thyroid nodule (B).
A B
The number of suspicious US feature of each thyroid nodule The total risk score of each thyroid nodule
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predictive power (Az=0.827) of the model using the number of 
suspicious US features of each thyroid nodule was not significantly 
superior to that (Az=0.833) of the model using the total risk score 
of each thyroid nodule (P=0.673). Penalized B-splines demonstrated 
that the risk of malignancy tended to increase as the number of 
suspicious US features and the total risk score increased in each 
thyroid nodule (Fig. 5). According to the Cochran-Armitage trend 
test, as the number of suspicious US features and the total risk score 
of each thyroid nodule increased, the risk of malignancy increased 
(P<0.001).
Discussion
Although multiple guidelines suggest that suspicious US features 
and nodule size should be considered when selecting thyroid 
nodules to be biopsied [4,6,9-12], a standardized lexicon for the 
characterization of thyroid nodules and guidelines for the selection 
of thyroid nodules needing FNA is still required to avoid unnecessary 
US and repeated FNA, and to reduce confusion among physicians 
and patients. Multiple studies have developed TI-RADS into a 
standardized US categorial system for predicting thyroid maligancy 
[14-18]. Horvath et al. [15] demonstrated 10 US patterns that 
encompass all types of thyroid nodules and retrospectively validated 
TI-RADS. However, it can be ambiguous and lack efficiency to select 
a specific category among 10 descriptive US patterns in everyday 
clinical practice. Park et al. [14] proposed an equation for predicting 
thyroid malignancy using a multiple logistic regression analysis. For 
using this method, calculation using a regression equation itself 
is difficult to apply in any circumstance due to the complicated 
equation and 12 variables of US findings. To overcome these 
limitation of previous studies, Kwak et al. [17] used the number 
of suspicious US features and calculated the fitted probability of 
malignancy. Nevertheless, there was a limitation to their approach 
in that each suspicious US feature was weighted identically [17]. 
Thereafter, they established a TI-RADS model applying a different 
risk score to each suspicious US feature [18].
Though US is noninvasive, a major limitation is its user dependency. 
Several studies have reported relatively good interobserver 
agreement in the final assessment for thyroid nodules [21,22]. 
However, diagnostic performance of US can greatly improve with 
the experience of the physician [23-25]. Therefore, experience can 
be a critical factor affecting the diagnostic accuracy of US. Most 
radiologists involved in previous studies about TI-RADS had more 
than 5 years of experience in thyroid imaging. Therefore, we wanted 
to determine whether these approaches were comparable when 
physicians were less experienced in thyroid imaging. Our study used 
two previous approaches in which the risk of malignancy increased 
proportionally to the number of suspicious malignant US features, 
where the predicted probability of malignancy had a tendency to 
increase along with the total risk score. We found that the results 
were comparable to previous studies even when the examinations 
were performed by less experienced physicians. The percentage 
of malignancy according to the number of suspicious US features 
is shown in Table 3. We found that as the number of suspicious 
US features increased, the risk of malignancy also increased (Fig. 
5A). This result was comparable to a previous study by Kwak et al. 
[17] and also supported the conclusion reached by the American 
Association of Clinical Endocrinologists, which noted that the 
coexistence of two or more suspicious US features indicates a 
much higher risk of thyroid cancer than does a single suspicious US 
feature [9]. Of 23 thyroid nodules assigned to TI-RADS 3, 17 nodules 
were examined by three physicians (physician 1,2, and 3) and there 
was no cancer. The remaining 6 nodules were examined by physician 
4 and one nodule (16.7%, 1/6) was malignant (Fig. 4). Overall, the 
risk of malignancy was 4% (1/23) in nodules classified as TI-RADS 3; 
this rate was in range of previous results (0%-9.6%) [14,16,17,26]. 
Of nineteen thyroid nodules assigned to TI-RADS 5, 2 malignant 
nodules (100%, 2/2), 9 malignant nodules (9/13, 69.2%), and 2 
malignant nodules (2/4, 50%) were examined by physician 2, 3, and 
4, respectively. Overall, the risk of malignancy was 68.4% (13/19) 
in nodules classified as TI-RADS 5 (Table 3). Table 4 shows the 
percentage of malignancy according to the sum of risk scores based 
on a previous study [18]. The risk of malignancy tended to increase 
as the risk score increased in our data and was again comparable 
to a previous study (Fig. 5B) [18]. The risk of malignancy in nodules 
with a total score of 14 was 80.1% (4 nodules of 5), which was 
comparable to the result of a previous study (90%) [18]. The risk of 
malignancy was 2.2% among nodules, with the sum of risk scores 
presenting as zero in this study, and previous studies reported a 
broad range of malignancy rates from 4.3% to 31.1% in nodules, 
which corresponds to those with a risk score of zero [14-16,18]. 
We calculated the area under the curve to assess the accuracy of 
two models predicting thyroid malignancy derived from the number 
of suspicious US features and total risk score, and the values were 
0.827 and 0.833, respectively. These results were similar to those of 
Kwak et al. [18] (0.872) and Hambly et al. [16] (0.794-0.904).
TI-RADS may improve management and the cost-effectiveness of 
follow-up by unifying the language and codes among radiologists. 
In addition, the two approaches tested in our study are very easy to 
apply in clinical practice. 
There are several potential limitations of our study. First, we did 
not determine interobserver variability or intraobserver reproducibility 
among the 4 radiologists since each radiologist prospectively 
recorded US features independently. Though interobserver variability Su Yeon Ko, et al.
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was not assessed, our study results demonstrated the reproducibility 
of two previously proposed models. Second, the reference standard 
was cytologic results in some thyroid nodules with benign results, 
and false-negative cytologic results may have existed for these 
nodules without surgical confirmation [27]. 
In conclusion, both the number of suspicious US features and the 
total risk score are applicable and show comparable results in the 
risk stratification of thyroid nodules by radiologists less experienced 
in thyroid imaging.
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